万邦医药：公司承接过的项目包括为客户提供肿瘤患者用药的临床试验研究技术服务，不涉及自主研发抗癌药物

Core Viewpoint - The company, Wanbang Medical (301520.SZ), clarified that it is a CRO (Contract Research Organization) and does not engage in the independent research and development of anti-cancer drugs, although it provides clinical trial research services for cancer medications [1]. Group 1 - The company specializes in providing professional pharmaceutical research outsourcing services to pharmaceutical companies and research institutions [1]. - Wanbang Medical has undertaken projects that include providing clinical trial research technical services for medications used by cancer patients [1].